Efficacy and safety of cholesterol-lowering treatment: prospective meta-analysis of data from 90 056 participants in 14 randomised trials of statins

This publication has 41 references indexed in Scilit:

• Statins and Prostate Cancer Risk: A Case-Control Study
  American Journal of Epidemiology, 2005
• Major Outcomes in Moderately Hypercholesterolemic, Hypertensive Patients Randomized to Pravastatin vs Usual Care: The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT-LLT)
  JAMA, 2002
• MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20 536 high-risk individuals: a randomised placebocontrolled trial
  Published by Elsevier ,2002
• The liver and lovastatin
  The American Journal of Cardiology, 2002
• Effect of greater LDL-C reductions on prognosis-the incremental decrease in endpoints through aggressive lipid lowering (IDEAL) trial
  Atherosclerosis, 1999
• Prevention of Cardiovascular Events and Death with Pravastatin in Patients with Coronary Heart Disease and a Broad Range of Initial Cholesterol Levels
  New England Journal of Medicine, 1998
• Protocol for a prospective collaborative overview of all current and planned randomized trials of cholesterol treatment regimens
  The American Journal of Cardiology, 1995
• Should there be a moratorium on the use of cholesterol lowering drugs?
  BMJ, 1992
• Lowering cholesterol concentrations and mortality: a quantitative review of primary prevention trials.
  BMJ, 1990
• Helsinki Heart Study: Primary-Prevention Trial with Gemfibrozil in Middle-Aged Men with Dyslipidemia
  New England Journal of Medicine, 1987